Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Lung Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07636252
What this trial is testing

Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma

Who this might be right for
Lung AdenocarcinomaMalignant Pleural Effusions (Mpe)
Sheba Medical Center 400
Early research (Phase 1)WithdrawnNCT02639767
What this trial is testing

Concurrent Pemetrexed/Cisplatin With Pleural Intensity Modulated Radiation Therapy for Patients With Unresectable Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
Memorial Sloan Kettering Cancer Center
Not applicableUnknownNCT02013063
What this trial is testing

Single Pulmonary Nodule Investigation

Who this might be right for
Malignant Neoplasm of Lung
University Hospital Southampton NHS Foundation Trust 375
Early research (Phase 1)Looking for participantsNCT06764771
What this trial is testing

BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

Who this might be right for
Advanced Malignant Tumors
Bristol-Myers Squibb 437
Testing effectiveness (Phase 2)WithdrawnNCT01353482
What this trial is testing

A Phase I/II Study of First Line Vorinostat With Pemetrexed-cisplatin, in Patients With Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University College, London
Testing effectiveness (Phase 2)Ended earlyNCT01612975
What this trial is testing

The Effect of Non-Steroidal Anti-Inflammatory Drug Naproxen on Pleural Effusion Formation After Lung Resection

Who this might be right for
Pleural EffusionPleural Effusion Malignant
McMaster University 7
Large-scale testing (Phase 3)Looking for participantsNCT05893888
What this trial is testing

A Study Evaluating the Safety and Efficacy of PRV111, PRV211, and PRV131 in Subjects With Oral and Lung Cancers

Who this might be right for
Oral Squamous Cell Carcinoma
Privo Technologies 40
Not applicableLooking for participantsNCT01950572
What this trial is testing

Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma

Who this might be right for
ThymomaStomach NeoplasmsPancreatic Neoplasms+3 more
National Cancer Institute (NCI) 1,000
Testing effectiveness (Phase 2)Study completedNCT05278975
What this trial is testing

Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma

Who this might be right for
Malignant Pleural EffusionMalignant Pleural MesotheliomaMesothelioma+3 more
RS Oncology LLC 50
Not applicableStudy completedNCT04716166
What this trial is testing

Incentive Spirometry and Upper Abdominal Laparoscopic Surgery

Who this might be right for
CholecystitisPerforated Duodenal UlcerDiaphragmatic Hernia+6 more
Riphah International University 60
Not applicableUnknownNCT04131231
What this trial is testing

Safety and Effectiveness of MPCD Therapy on the Treatment of Malignant Pleural Effusion

Who this might be right for
Lung CancerBreast CancerMalignant Pleural Effusion
Peking Union Medical College 248
Not applicableStudy completedNCT01991418
What this trial is testing

Early Warning Study of Serum Thioredoixn Reductase Activity in Excised Non-small Cell Lung Cancers (EWSOTRILC)

Who this might be right for
Non-small Cell Lung Cancer Stage INon-small Cell Lung Cancer Stage IINon-small Cell Lung Cancer Stage IIIA
Hunan Province Tumor Hospital 165
Testing effectiveness (Phase 2)Study completedNCT00787410
What this trial is testing

An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma

Who this might be right for
Mesothelioma
AstraZeneca 23
Large-scale testing (Phase 3)Study completedNCT03080883
What this trial is testing

Apixaban in Preventing Secondary Cancer Related Venous Thrombosis in Cancer Patients Who Have Completed Anticoagulation Therapy

Who this might be right for
Cerebral Vein ThrombosisDeep Vein ThrombosisHematopoietic and Lymphoid Cell Neoplasm+4 more
Academic and Community Cancer Research United 370
Early research (Phase 1)WithdrawnNCT01836341
What this trial is testing

Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation

Who this might be right for
Non-small Cell Lung Cancer
Memorial Sloan Kettering Cancer Center
Not applicableStudy completedNCT02755454
What this trial is testing

Perfusion CT Imaging in Lung Cancer With SBRT

Who this might be right for
Lung Cancer
University Health Network, Toronto 9
Early research (Phase 1)Ended earlyNCT05241873
What this trial is testing

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

Who this might be right for
Lung Neoplasm MalignantCarcinoma, Non-Small-Cell LungRespiratory Tract Neoplasms+17 more
Blueprint Medicines Corporation 103
Early research (Phase 1)Looking for participantsNCT05969041
What this trial is testing

Study of MT-302 in Adults With Advanced or Metastatic Epithelial Tumors

Who this might be right for
Epithelial Tumors, Malignant
Myeloid Therapeutics 48
Not applicableLooking for participantsNCT05113017
What this trial is testing

The Effectiveness and Safety of SBRT in the Treatment of Patients With MPLC After Surgery (SMILE)

Who this might be right for
The Efficacy and Safety of SBRT in MPLC
Fang Wu 40
Testing effectiveness (Phase 2)Study completedNCT00343291
What this trial is testing

Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 121
Next Page